Dr. Achim Plum is Chief Business Officer of the Curetis Group, a Stuttgart, Germany, based diagnostics company focusing on solutions for molecular microbiology. In this function, he oversees all corporate development, business development and strategic activities. He is also one of the two Managing Directors of Ares Genetics GmbH, Curtis wholly owned Subsidiary in Vienna, Austria, dedicated to data- and BioIT-driven approaches in the fight against antimicrobial resistance. He joined the Curetis Group from a senior management position with Siemens Healthcare, heading the life science and diagnostics research in the Siemens Healthcare Technology Center. Prior to Siemens, Dr. Plum worked for eight years with the publicly traded cancer molecular diagnostics company Epigenomics AG, in various functions of increasing responsibility along the diagnostics value chain starting in R&D Management and eventually heading all business operations as Senior Vice President Business and Strategy. Following undergraduate studies at the University of Bonn (Germany) and the University of East Anglia in Norwich (UK), Dr. Plum obtained his PhD in molecular genetics from the University of Bonn for developing and studying novel genetic models of human diseases.